This inventor holds 1 USPTO granted patent. Top assignee: Sanofi. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Jochen Sieber: Innovator in Blood Glucose Measurement Technology
Introduction
Jochen Sieber is a notable inventor based in Frankfurt, Germany. He has made significant contributions to the field of medical technology, particularly in the area of blood glucose measurement. His innovative work has the potential to improve the management of diabetes and enhance patient care.
Latest Patents
Jochen Sieber holds a patent for a "Pattern recognition engine for blood glucose measurements." This patent relates to systems, methods, and apparatus for recognizing patterns in blood glucose measurements. The invention involves a computer-implemented blood glucose analysis method that includes receiving multiple blood glucose measurements taken over various temporal frames. It identifies hypoglycaemic and hyperglycaemic measurements, infers temporal relationships between them, and outputs suggested causal drivers for these relationships. This innovative approach aims to provide better insights into blood glucose fluctuations and their causes.
Career Highlights
Jochen Sieber is currently employed at Sanofi, a global healthcare company dedicated to supporting people through their health challenges. His work at Sanofi allows him to collaborate with other experts in the field and contribute to advancements in medical technology. His dedication to innovation is evident in his patent and ongoing research efforts.
Collaborations
Some of Jochen Sieber's coworkers include Anton Petkov and Sandro Girolami. Their collaboration fosters a creative environment that encourages the development of groundbreaking solutions in healthcare.
Conclusion
Jochen Sieber's contributions to blood glucose measurement technology exemplify the impact of innovation in healthcare. His patent and work at Sanofi highlight the importance of advancing medical technology for better patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
